193 related articles for article (PubMed ID: 24574518)
1. DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.
Han C; Zhao R; Liu X; Srivastava A; Gong L; Mao H; Qu M; Zhao W; Yu J; Wang QE
Mol Cancer Res; 2014 May; 12(5):784-94. PubMed ID: 24574518
[TBL] [Abstract][Full Text] [Related]
2. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer.
Xiang T; Long H; He L; Han X; Lin K; Liang Z; Zhuo W; Xie R; Zhu B
Oncogene; 2015 Jan; 34(2):165-76. PubMed ID: 24362529
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.
Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.
Silva IA; Bai S; McLean K; Yang K; Griffith K; Thomas D; Ginestier C; Johnston C; Kueck A; Reynolds RK; Wicha MS; Buckanovich RJ
Cancer Res; 2011 Jun; 71(11):3991-4001. PubMed ID: 21498635
[TBL] [Abstract][Full Text] [Related]
6. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.
Zhao R; Han C; Eisenhauer E; Kroger J; Zhao W; Yu J; Selvendiran K; Liu X; Wani AA; Wang QE
Mol Cancer Res; 2014 Mar; 12(3):370-80. PubMed ID: 24249678
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin induces stemness in ovarian cancer.
Wiechert A; Saygin C; Thiagarajan PS; Rao VS; Hale JS; Gupta N; Hitomi M; Nagaraj AB; DiFeo A; Lathia JD; Reizes O
Oncotarget; 2016 May; 7(21):30511-22. PubMed ID: 27105520
[TBL] [Abstract][Full Text] [Related]
8. The identification of the biological characteristics of human ovarian cancer stem cells.
Yan HC; Fang LS; Xu J; Qiu YY; Lin XM; Huang HX; Han QY
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3497-503. PubMed ID: 25491627
[TBL] [Abstract][Full Text] [Related]
9. S100B Mediates Stemness of Ovarian Cancer Stem-Like Cells Through Inhibiting p53.
Yang T; Cheng J; Yang Y; Qi W; Zhao Y; Long H; Xie R; Zhu B
Stem Cells; 2017 Feb; 35(2):325-336. PubMed ID: 27501952
[TBL] [Abstract][Full Text] [Related]
10. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
11. Neil 1 deficiency facilitates chemoresistance through upregulation of RAD18 expression in ovarian cancer stem cells.
Shukla D; Mandal T; Srivastava AK
Biochem Biophys Res Commun; 2024 Jun; 712-713():149907. PubMed ID: 38636303
[TBL] [Abstract][Full Text] [Related]
12. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
14. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
15. Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.
Srivastava AK; Han C; Zhao R; Cui T; Dai Y; Mao C; Zhao W; Zhang X; Yu J; Wang QE
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):4411-6. PubMed ID: 25831546
[TBL] [Abstract][Full Text] [Related]
16. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
17. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.
Srivastava AK; Banerjee A; Cui T; Han C; Cai S; Liu L; Wu D; Cui R; Li Z; Zhang X; Xie G; Selvendiran K; Patnaik S; Karpf AR; Liu J; Cohn DE; Wang QE
Cancer Res; 2019 May; 79(9):2314-2326. PubMed ID: 30894370
[TBL] [Abstract][Full Text] [Related]
19. PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.
Parte S; Virant-Klun I; Patankar M; Batra SK; Straughn A; Kakar SS
Stem Cell Rev Rep; 2019 Dec; 15(6):866-879. PubMed ID: 31482269
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
Tang S; Xiang T; Huang S; Zhou J; Wang Z; Xie R; Long H; Zhu B
Cancer Lett; 2016 Jun; 376(1):137-47. PubMed ID: 27033454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
